Folic acid-functionalized PEGylated niosomes co-encapsulated cisplatin and doxoribicin exhibit enhanced anticancer efficacy
Abstract The medical field is faced with the difficult task of developing a new approach to curing cancer, which is prevalent in organs such as the breast and ovaries and has a high mortality rate. Since chemotherapy is the conventional method of treatment, efforts are being made to improve it to he...
Main Authors: | Mona Safari Sharafshadeh, Farzaneh Tafvizi, Parvin Khodarahmi, Somayeh Ehtesham |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | Cancer Nanotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12645-024-00252-8 |
Similar Items
-
pH-Responsive PEGylated Niosomal Nanoparticles as an Active-Targeting Cyclophosphamide Delivery System for Gastric Cancer Therapy
by: Farnaz Khodabakhsh, et al.
Published: (2022-08-01) -
Empowering Cancer Therapy: Comparing PEGylated and Non-PEGylated Niosomes Loaded with Curcumin and Doxorubicin on MCF-7 Cell Line
by: Shaghayegh Saharkhiz, et al.
Published: (2023-10-01) -
Cellular Uptake and Transport Mechanism Investigations of PEGylated Niosomes for Improving the Oral Delivery of Thymopentin
by: Mengyang Liu, et al.
Published: (2024-03-01) -
Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy
by: Mahdie Hemati, et al.
Published: (2019-12-01) -
Aerosolized Niosome Formulation Containing Gemcitabine and Cisplatin for Lung Cancer Treatment: Optimization, Characterization and In Vitro Evaluation
by: Norfatin Izzatie Mohamad Saimi, et al.
Published: (2021-01-01)